arrow
T

Takashi Matono

University of Osaka
H指数:12
被引数:482

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan

难治性耐药(DTR)、治疗及结果:日本IMP型碳青霉烯酶占主导的碳青霉烯耐药肠杆菌科细菌感染

2026-06-020
PRE
Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS

日本成人中JN.1适应型COVID-19疫苗针对医疗就诊SARS-CoV-2感染和COVID-19住院的有效性(2024年10月至2025年4月):VERSUS

Vaccine
IF3.5
2026-04-020
OAAI
Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of Onset

基于发病场所的日本碳青霉烯耐药革兰氏阴性菌感染特征

2025-10-010
OAAI
Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network
2025-03-060
OAAI
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
2024-02-081
OA